Reviva Pharmaceuticals Holdings, Inc. Cash and Due from Banks
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Cash and Due from Banks of $1.30 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:CashAndDueFromBanks · last filed 2026-08-12
- 2026-06-30: Cash and Due from Banks $1.30M.
- 2026-03-31: Cash and Due from Banks $1.16M.
- 2025-12-31: Cash and Due from Banks $1.21M.
- 2025-09-30: Cash and Due from Banks $1.27M.
| Period end | Cash and Due from Banks |
|---|---|
| 2026-06-30 | $1.30M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.21M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.34M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.43M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.27M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.36M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $1.16M 10-K · filed 2025-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |